FDA approves cancer drug by Allos Therapeutics
Submitted by Jason Ramsey on Sat, 09/26/2009 - 14:44
The new cancer drug, Folotyn, by Allos Therapeutics, was approved quickly by the FDA to treat the most chronic and aggressive kinds of white blood cell cancers, thereby increasing its share prices by 6 percent.
Latest News
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Product Launch
New Zealand News
- After Suspected Botulism, CFIA Warns People
- Health Care Education Necessary for the Future of Province: Analysts
- B.C. Government Grants $700,000 for Managing Facial Deformities
- Michelle Shocked delivers hate speech about homosexuality at her gig
- Guess who Justin Bieber got burned by?!! His ex-girlfriend Selena Gomez